Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia in Remission”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00006451
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT00002554
What this trial is testing

Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT01757535
What this trial is testing

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 472
Testing effectiveness (Phase 2)Ended earlyNCT01135329
What this trial is testing

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Who this might be right for
LymphomaLeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Ended earlyNCT01794169
What this trial is testing

Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Karolinska University Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT00450983
What this trial is testing

Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01698905
What this trial is testing

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 163
Not applicableLooking for participantsNCT06256627
What this trial is testing

The Maintenance Treatment of "ITIVA" in AML Patients

Who this might be right for
Acute Myeloid LeukemiaMaintenance TreatmentMinor Residue Disease+5 more
Henan Cancer Hospital 130
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Testing effectiveness (Phase 2)Active Not RecruitingNCT05197426
What this trial is testing

Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Bristol-Myers Squibb 19
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06954987
What this trial is testing

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 244
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Early research (Phase 1)Study completedNCT00009698
What this trial is testing

Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 1
Not applicableStudy completedNCT01005277
What this trial is testing

Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1Adult Acute Promyelocytic Leukemia With PML-RARA+6 more
Children's Oncology Group 2,000
Not applicableNot Yet RecruitingNCT07521124
What this trial is testing

ABC Maintenance Therapy for AML

Who this might be right for
Acute Myeloid Leukemia (AML) in Remission
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT04626024
What this trial is testing

Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

Who this might be right for
Chronic Myeloid LeukemiaChronic Myeloid Leukemia, BCR/ABL-Positive, in RemissionChronic Myeloid Leukemia in Remission
Baylor College of Medicine 17
Large-scale testing (Phase 3)Study completedNCT05188326
What this trial is testing

Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients

Who this might be right for
Acute Myeloid Leukemia
Associazione Qol-one 54
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT01841333
What this trial is testing

PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionRecurrent Adult Acute Myeloid Leukemia
University of Colorado, Denver 31
Next Page